Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cerus Corporation

Clinical trials sponsored by Cerus Corporation, explained in plain language.

Cerus Corporation CERS NASDAQ

Develops blood safety products, including pathogen reduction systems for blood components.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 2 Completed 2

New blood treatment aims to make transfusions safer

Knowledge-focused Recruiting now

This study tests a device called the INTERCEPT Blood System that treats red blood cells to kill germs. Researchers want to see if treated red blood cells survive as well as untreated ones after 35 days of storage. About 70 healthy adults will donate blood, have it treated or not,…

Phase: PHASE2 • Sponsor: Cerus Corporation • Aim: Knowledge-focused

Last updated Jun 27, 2026 07:54 UTC